Nexentis Technologies Inc. NXTS · Stock Open Nexentis Technologies Inc. in new tab
Nexentis Technologies Inc. Analysis (NXTS)
Is Nexentis Technologies Inc. a good investment? Nexentis Technologies Inc. (NXTS) is currently trading at 1.43 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.08. This relatively low multiple may signal that Nexentis Technologies Inc. is undervalued compared to historical market norms.
Earnings Schedule: Nexentis Technologies Inc. is expected to release its next earnings report on Dec. 2, 2026.
Investor FAQ
Does Nexentis Technologies Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nexentis Technologies Inc.?
Nexentis Technologies Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Dec. 2, 2026. The company currently has a trailing EPS of 17.39.
Company Profile
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
| Split Date | Split Ratio to 1 |
|---|---|
| June 13, 2019 | Needs review |
Community Discussion